Stockscreener 앱 받기
1.07
1.83%
-0.02
시간 외 거래:
1.06
-0.01
-0.93%
전일 마감가:
$1.09
열려 있는:
$1.07
하루 거래량:
754.54K
Relative Volume:
0.66
시가총액:
$147.32M
수익:
$4.35M
순이익/손실:
$-45.53M
주가수익비율:
-0.9907
EPS:
-1.08
순현금흐름:
$-44.79M
1주 성능:
+4.90%
1개월 성능:
-16.41%
6개월 성능:
-32.70%
1년 성능:
+7.17%
1일 변동 폭
$1.04
$1.08
1주일 범위
$1.00
$1.10
52주 변동 폭
$0.7501
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
LUCD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.07 | 142.90M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
128.54 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.96 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.29 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.02 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.75 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com
Live market analysis of Lucid Diagnostics Inc.Weekly Market Report & Long Hold Capital Preservation Tips - newser.com
Why retail investors favor Lucid Diagnostics Inc. stockAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
Is Lucid Diagnostics Inc. stock oversold or undervaluedMarket Growth Report & Pattern Based Trade Signal System - newser.com
Measuring Lucid Diagnostics Inc.’s beta against major indices - newser.com
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges - MSN
Combining machine learning predictions for Lucid Diagnostics Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
Why Lucid Diagnostics Inc. stock is considered a top pickJuly 2025 Momentum & Community Consensus Picks - newser.com
Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaEarnings Performance Report & Weekly Momentum Stock Picks - newser.com
Earnings call transcript: Lucid Diagnostics Q3 2025 reports revenue growth and strategic advancements - Investing.com Nigeria
Lucid Diagnostics Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:LUCD) 2025-11-14 - Seeking Alpha
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Eastern Progress
How supply chain issues affect Lucid Diagnostics Inc. stockJuly 2025 Setups & Daily Profit Focused Screening - Fundação Cultural do Pará
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates - MSN
Lucid Diagnostics Gains Medicare Support for EsoGuard - MSN
Is Lucid Diagnostics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Needham reiterates Buy rating on Lucid Diagnostics stock amid EsoGuard growth By Investing.com - Investing.com South Africa
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Pa - GuruFocus
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Lucid Diagnostics to Participate in the Canaccord Genuity MedTec - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2025 Earnings Call Transcript - Insider Monkey
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q3 2025 Earnings Conference - 富途牛牛
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results - MarketScreener
Needham reiterates Buy rating on Lucid Diagnostics stock amid EsoGuard growth - Investing.com Nigeria
Needham Reiterates Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Lucid Diagnostics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Australia
Lucid Diagnostics Inc (LUCD) Q3 2025 Earnings Call Highlights: Strategic Growth Plans Amidst ... By GuruFocus - Investing.com Canada
Lucid Diagnostics Reports Q3 2025 Financial Results - TipRanks
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
1.36%
자본화:
|
볼륨(24시간):